Back
Autolus Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
51
AUTL
Autolus Therapeutics PLC
Last Price:
2.94
Seasonality Move:
0.84%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.66
Seasonality Move:
50.57%
Buy
51
Autolus Therapeutics PLC (AUTL)
is a Buy
Is Autolus Therapeutics PLC a Buy, Sell or Hold?
- The current Autolus Therapeutics PLC [AUTL] share price is $2.84. The Score for AUTL is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- AUTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AUTL Stock Price Chart
What is Autolus Therapeutics PLC's stock price today?
-
The Autolus Therapeutics PLC share price today is $2.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
AUTL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 32.8 | Sell |
Chaikin Money Flow: | 1594280 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.09 - 4.33) | Sell |
Bollinger Bands (100): | (3.49 - 4.37) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 36.24 | Sell |
Chaikin Money Flow: | -608296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.66 - 0.82) | Sell |
Bollinger Bands (100): | (0.81 - 1.21) | Sell |
AUTL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.04 | Sell |
20-day SMA: | 3.5 | Sell |
50-day SMA: | 3.8 | Sell |
200-day SMA: | 4.45 | Sell |
8-day EMA: | 3.05 | Sell |
20-day EMA: | 3.39 | Sell |
50-day EMA: | 3.71 | Sell |
200-day EMA: | 4.08 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.73 | Sell |
50-day SMA: | 0.85 | Sell |
200-day SMA: | 1.12 | Sell |
8-day EMA: | 0.67 | Sell |
20-day EMA: | 0.73 | Sell |
50-day EMA: | 0.83 | Sell |
200-day EMA: | 1 | Sell |
Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.11 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Autolus Therapeutics PLC Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |